SLM Corp (SLM): what the price assumes

In the published model solve dated 2026-Q2, anchored at $27.47, SLM Corp (SLM) is priced for -4.1% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-11.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/SLM

Headline

FieldValue
TickerSLM
CompanySLM Corp
Sector / IndustryFinancial Services
Current price$27.47/sh

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Implied growth-4.1%
Multiple paid6x operating income

Solve inputs: computed at a 12.9% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~3.9pp.

How unusual the bet is: n/a

ReferenceValue
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and earnings-power and relative-multiple value, while growth-DCF lands below the price. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset0.54x4justifies
Earnings0.48x2justifies
Relative0.64x4justifies
Growth1.52x1expensive

Families that justify the price: Asset, Earnings, Relative Families that call it expensive: Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 6.3%); the inversion above states its own rate.

Per-Model Detail (n=11)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$0.00noNegative/zero FCF — equity value floored at $0
DCF Exit MultipleGrowth$0.00noNegative/zero FCF or EBITDA — equity value floored at $0
Relative ValuationRelative$42.840.64xyesP/E 12x (static sector reference · 2026-04), scenarios: 10.2x / 12.0x / 13.8x (bear / base = reference held flat / bull), EV/EBITDA N/Ax
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$41.770.66xyesBV/sh $13.00, ROE (TTM) 29.7%, ke 9.3%
Two-Stage Excess ReturnAsset$77.130.36xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$18.081.52xyesRev $1.5B, growth -1% (input: historical growth; tapered), Terminal P/S: 3.0x / 3.6x / 4.1x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$42.840.64xyesEPS $3.57, growth 1% (input: historical EPS growth), PEG=5.88 (Overvalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarningsno
Residual IncomeAsset$63.590.43xyesBV $13.00 + 5yr PV of (ROE (TTM) 29.7% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham NumberAsset$32.310.85xyes√(22.5 × EPS $3.57 × BVPS $13.00) — Graham's conservative floor
EV/EBITDA RelativeRelativeno
FCF YieldEarningsno
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarnings$115.190.24xyesEPS $3.57 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAssetno
P/Sales SectorRelative$22.981.20xyesRevenue $1.46B × sector P/S 3.0x
PEG Fair ValueRelative$133.880.21xyesEPS $3.57 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$38.590.71xyesEPS $3.57 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Net debt$1.3b
Net debt / NOPAT (after-tax)1.76x
Net debt / operating income (pre-tax)1.28x
Share count CAGR (buyback)-7.9%
Burning cashyes

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

Bull Case

Sallie Mae's capital position tells you what management thinks of its own franchise: the share count has shrunk about 8.4% a year for four years, one of the most aggressive sustained retirement paces in financials, funded by a machine that originates private student loans, sells tranches at a premium, and recycles the capital into buybacks. The first quarter of 2026 ran the full playbook: $2.9 billion of originations, up 5% year over year, $3.3 billion of loan sales, a 5.29% net interest margin, and diluted earnings of $1.54 per share against $1.40 a year earlier. Management raised full-year 2026 guidance to $3.10 to $3.20 of diluted earnings per share on the strength of it. A lender earning a 30.7% trailing return on equity while retiring nearly a tenth of its shares annually is compounding per-share value on two axes at once.

Then there is the policy gift. The company's own 10-K lays it out: "On July 4, 2025, H.R.1 ('H.R.1') was enacted into law. H.R.1 implements significant reforms to the federal student loan program", including "Eliminating Graduate PLUS loans" and "Limiting Parent PLUS loans to $20,000 per student, per year, with an aggregate, per student limit of $65,000" (FY2025 10-K, accession 0001032033-26-000011). Those federal programs were Sallie Mae's largest competitor; the same filing notes that government loan availability "affect[s] the demand for Private Education Loans because students and their families often rely on Private Education Loans to bridge the gap" (accession 0001032033-26-000011). As of July 1, 2026 the Grad PLUS phase-out is live, and Sallie Mae moved immediately: a new Parent Loan launched June 30, 2026, plus expanded Graduate and Law School loans covering up to 100% of school-certified cost of attendance. The gap the government just legislated into existence is measured in billions of annual originations, and the incumbent with school-channel relationships is first in line for it.

The credit book supports the expansion case rather than restraining it. As of March 31, 2026, 96.0% of loans in repayment were current, with only 1.0% delinquent past 90 days, and the filing states the reserve philosophy plainly: "We believe the allowance for credit losses is appropriate to cover lifetime expected losses incurred in the loan portfolios" (accession 0001032033-26-000011). At about 5 times operating income, the price sits below what even a 5% annual decline in operating profit would warrant. A franchise entering the largest addressable-market expansion in its modern history, priced for erosion, is the bull case in one sentence.

Bear Case

The structural truth: this is a monoline. The 10-K quantifies it without blinking: "At December 31, 2025, approximately 71 percent of our total assets, and 83 percent of our total assets excluding cash and cash equivalents, were comprised of Private Education Loans" (FY2025 10-K, accession 0001032033-26-000011). One asset class, one borrower demographic, one political jurisdiction. The stock is cheap on every static measure because the market prices that concentration, and it has history on its side: private student credit is exactly the kind of book that looks pristine at 96% current until a recession meets a cohort of borrowers whose degrees did not price the way the underwriting assumed. The H.R.1 windfall cuts the same way; a market suddenly flooded with graduate and parent borrowers who previously qualified for federal cost-of-attendance loans is a market whose marginal new borrower is riskier than the incumbent book, and growth into that cohort is where credit mistakes get made.

The earnings engine has a dependency worth naming. Reported earnings lean on loan sales ($3.3 billion in the first quarter alone) that convert future interest margin into present gains. That model works while buyers pay premiums for student-loan paper; it compresses if securitization demand cools or credit spreads widen, and the filing itself concedes "We may not be able to sell loans at prices, in volumes, or on a" favorable basis (accession 0001032033-26-000011, risk factors). The 30.7% trailing return on equity, the number that makes every book-value method scream cheap, is partly a function of that sale cadence and of a balance sheet deliberately run thin on equity; the same earnings at a more conservative capital ratio would show a lower return and a smaller gap to the price.

Policy gives, and policy is the risk. This company's addressable market was just redrawn by one act of Congress, which proves the market can be redrawn again, in either direction, by the next one. Loan forgiveness proposals, servicing regulation, state collection-practice changes (all named in the filing's own risk factors, accession 0001032033-26-000011) sit permanently over the multiple. The market pays about 5 times operating income and prices in decline; the bear case is that for a monoline consumer lender whose fate rides on political weather and on underwriting a newly expanded, less-tested borrower pool, a decline-shaped price is not mispricing but a fair charge for the tail. The buyback pace, for all its per-share arithmetic, also means the company is retiring capital it might wish it had in the loss scenario.

Valuation

The market pays about 5 times Sallie Mae's company-wide operating income, a multiple so low that the price sits below what even a 5% annual operating-profit decline would warrant at the framework's cost of capital. There is no growth assumption to interrogate here; the price embeds contraction. Against that, the raised 2026 guidance of $3.10 to $3.20 in diluted earnings per share puts today's $24.96 (July 2026) at roughly 7.8 times forward guided earnings, and trailing earnings of $3.60 per share put it under 7 times. For a lender earning a trailing 30.7% return on equity on $12.32 of book value per share, roughly 2 times book, the price implies the market expects that return on equity to fade hard.

The method families agree with unusual unanimity for a value name. Book-value-plus-profitability reads land around double the price: the trailing return-on-equity capitalizations reach $41 to $77 depending on how long the excess return persists. Earnings capitalizations land 55% or more above the price, and sector-relative multiples (a 12-times sector median P/E against this sub-7-times print) land near $46. Only the sales-based projection sits below, and it is the least apt frame for a spread lender. When every profitability-anchored family says cheap and the price says decline, the disagreement is about persistence: the methods extend today's returns, and the market does not believe them. The concentration is why, and it is filing-quantified: "approximately 71 percent of our total assets" in Private Education Loans (FY2025 10-K, accession 0001032033-26-000011). The revenue engine's other half runs on loan sales, $3.3 billion in the first quarter, which converts margin into gains and keeps capital velocity high.

The balance-sheet frame for a bank is capital-return capacity, not coverage math. On that frame: net interest margin of 5.29%, a repayment book 96.0% current with 1.0% past 90 days, and a share count down about 8.4% a year for four years, with the filing's repurchase authorization standing behind it (accession 0001032033-26-000011). The July 1, 2026 activation of H.R.1's federal loan caps opens the largest origination opportunity in the company's modern history, and it is also the swing variable the 5-times multiple is discounting: if the expanded borrower pool seasons at anything like the current book's credit quality, the price is paying for a decline that never arrives; if it seasons worse, the market was early, not wrong.

Catalysts

July 1, 2026 was the structural catalyst: H.R.1's federal student-loan caps took effect, eliminating Grad PLUS loans for new borrowing and capping graduate borrowing at $20,500 per year ($100,000 lifetime) and professional-degree borrowing at $50,000 per year ($200,000 lifetime). Graduate programs were built around cost-of-attendance federal funding, so the gap between federal caps and tuition now flows to private lenders. Sallie Mae pre-positioned: a new Parent Loan launched June 30, 2026, alongside expanded Graduate and Law School loans covering up to 100% of school-certified cost of attendance with no origination fees. The fall 2026 academic-year origination season, reported across the third-quarter print, is the first hard evidence of how much of that redirected demand Sallie Mae captures.

The first quarter set a strong base and a raised bar: diluted EPS of $1.54 versus $1.40 a year earlier, net income to common of $304 million, originations up 5% to $2.9 billion, a 5.29% net interest margin, $3.3 billion of loan sales, and full-year guidance lifted to $3.10 to $3.20 per share. The next quarterly report, on the company's usual late-July cadence, updates peak-season origination commitments and, more importantly, credit: the March-quarter book stood 96.0% current with 1.0% delinquent past 90 days, and any drift in those lines as the borrower pool expands is the single most consequential data point for the multiple.

Watch three mechanics through year-end: the loan-sale program's execution (volumes and premiums are the swing factor in reported gains), the buyback cadence that has retired roughly 8.4% of shares annually, and competitive response, since the same H.R.1 opportunity is drawing fintech and bank lenders into graduate and parent lending. Market-share evidence in the fall season decides whether the policy windfall accrues to the incumbent or gets competed away.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Q1 2026 earnings release, April 23, 2026 · Sallie Mae product announcements, June 30, 2026 · federal student aid coverage of H.R.1 implementation, July 2026 · Sallie Mae product announcements, June 2026

View the full interactive SLM report on boothcheck